LivaNova ROE 2010-2025 | LIVN
Current and historical return on equity (ROE) values for LivaNova (LIVN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| LivaNova ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.22B | $1.03B | -18.10% |
| 2024-12-31 | $0.06B | $1.32B | 4.95% |
| 2024-09-30 | $0.02B | $1.31B | 1.82% |
| 2024-06-30 | $-0.02B | $1.24B | -1.37% |
| 2024-03-31 | $-0.03B | $1.22B | -2.58% |
| 2023-12-31 | $0.02B | $1.28B | 1.37% |
| 2023-09-30 | $0.00B | $1.23B | 0.24% |
| 2023-06-30 | $-0.10B | $1.24B | -8.04% |
| 2023-03-31 | $-0.08B | $1.23B | -6.74% |
| 2022-12-31 | $-0.09B | $1.21B | -6.98% |
| 2022-09-30 | $-0.09B | $1.15B | -7.42% |
| 2022-06-30 | $-0.03B | $1.28B | -2.24% |
| 2022-03-31 | $-0.10B | $1.29B | -8.18% |
| 2021-12-31 | $-0.14B | $1.30B | -11.46% |
| 2021-09-30 | $-0.41B | $1.31B | -36.58% |
| 2021-06-30 | $-0.39B | $1.04B | -33.82% |
| 2021-03-31 | $-0.42B | $1.07B | -34.41% |
| 2020-12-31 | $-0.35B | $1.11B | -26.92% |
| 2020-09-30 | $-0.21B | $1.35B | -15.46% |
| 2020-06-30 | $-0.16B | $1.33B | -11.70% |
| 2020-03-31 | $-0.11B | $1.39B | -7.30% |
| 2019-12-31 | $-0.16B | $1.38B | -10.81% |
| 2019-09-30 | $-0.22B | $1.50B | -14.94% |
| 2019-06-30 | $-0.26B | $1.48B | -16.74% |
| 2019-03-31 | $-0.22B | $1.49B | -13.29% |
| 2018-12-31 | $-0.19B | $1.50B | -11.03% |
| 2018-09-30 | $-0.09B | $1.79B | -5.05% |
| 2018-06-30 | $-0.06B | $1.78B | -3.06% |
| 2018-03-31 | $-0.02B | $1.82B | -1.30% |
| 2017-12-31 | $-0.03B | $1.82B | -1.42% |
| 2017-09-30 | $0.06B | $1.91B | 3.11% |
| 2017-06-30 | $0.03B | $1.84B | 1.46% |
| 2017-03-31 | $-0.01B | $1.74B | -0.68% |
| 2016-12-31 | $-0.06B | $1.71B | -3.51% |
| 2016-06-30 | $-0.06B | $1.82B | -3.90% |
| 2016-03-31 | $-0.09B | $1.83B | -9.20% |
| 2015-10-31 | $-0.03B | $0.28B | -18.21% |
| 2015-07-31 | $0.04B | $0.29B | 24.56% |
| 2015-06-30 | $0.04B | 29.20% | |
| 2015-03-31 | $0.06B | 29.32% | |
| 2014-10-31 | $0.05B | $0.27B | 17.42% |
| 2014-07-31 | $0.04B | $0.26B | 16.82% |
| 2013-10-31 | $0.04B | $0.24B | 15.57% |
| 2013-07-31 | $0.04B | $0.24B | 16.11% |
| 2012-10-31 | $0.03B | $0.21B | 17.07% |
| 2012-07-31 | $0.03B | $0.19B | 15.21% |
| 2011-10-31 | $0.02B | $0.17B | 13.47% |
| 2011-07-31 | $0.04B | $0.17B | 23.04% |
| 2010-10-31 | $0.04B | $0.16B | 33.47% |
| 2010-07-31 | $0.07B | $0.12B | 63.16% |
| 2009-10-31 | $0.07B | $0.09B | 167.90% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.495B | $1.253B |
| LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $192.825B | 84.46 |
| Thermo Fisher Scientific (TMO) | United States | $159.102B | 19.25 |
| Edwards Lifesciences (EW) | United States | $45.274B | 29.68 |
| Alcon (ALC) | Switzerland | $43.909B | 29.67 |
| IDEXX Laboratories (IDXX) | United States | $43.641B | 50.15 |
| DexCom (DXCM) | United States | $32.772B | 50.65 |
| IQVIA Holdings (IQV) | United States | $28.132B | 15.76 |
| Mettler-Toledo (MTD) | United States | $25.049B | 29.79 |
| STERIS (STE) | Ireland | $23.871B | 26.29 |
| Waters (WAT) | United States | $21.247B | 29.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.939B | 0.00 |
| Hologic (HOLX) | United States | $14.558B | 15.82 |
| Sysmex ADR (SSMXY) | Japan | $10.852B | 30.79 |
| Penumbra (PEN) | United States | $9.708B | 76.19 |
| Masimo (MASI) | United States | $9.164B | 33.80 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.858B | 0.00 |
| Teleflex (TFX) | United States | $5.384B | 8.89 |
| TransMedics (TMDX) | United States | $4.401B | 95.66 |
| Integer Holdings (ITGR) | United States | $4.232B | 22.17 |
| PROCEPT BioRobotics (PRCT) | United States | $3.130B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.305B | 26.43 |
| Veracyte (VCYT) | United States | $2.140B | 30.02 |
| Elekta AB (EKTAY) | Sweden | $1.918B | 17.24 |
| Alphatec Holdings (ATEC) | United States | $1.598B | 0.00 |
| Artivion (AORT) | United States | $1.313B | 123.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.030B | 5.48 |
| Pulse Biosciences (PLSE) | United States | $0.998B | 0.00 |
| SiBone (SIBN) | United States | $0.780B | 0.00 |
| IRadimed (IRMD) | United States | $0.769B | 39.04 |
| Beta Bionics (BBNX) | United States | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.579B | 9.01 |
| RxSight (RXST) | United States | $0.533B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.533B | 12.49 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.499B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.444B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.438B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.395B | 10.51 |
| Pacific Biosciences Of California (PACB) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.387B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.379B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.238B | 14.41 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| CVRx (CVRX) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.153B | 0.00 |
| LENSAR (LNSR) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.025B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.44 |